Kestra Medical Technologies (NASDAQ:KMTS) CFO Sells $680,307.56 in Stock

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) CFO Vaseem Mahboob sold 26,287 shares of the stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $25.88, for a total transaction of $680,307.56. Following the completion of the transaction, the chief financial officer owned 60,609 shares in the company, valued at $1,568,560.92. This represents a 30.25% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Vaseem Mahboob also recently made the following trade(s):

• On Tuesday, August 4th, Vaseem Mahboob sold 6,995 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $24.68, for a total transaction of $172,636.60.
• On Monday, August 3rd, Vaseem Mahboob sold 5,391 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $23.80, for a total transaction of $128,305.80.
• On Friday, July 31st, Vaseem Mahboob sold 8,817 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $22.61, for a total value of $199,352.37.
• On Thursday, July 30th, Vaseem Mahboob sold 3,980 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $22.75, for a total value of $90,545.00.

Kestra Medical Technologies Stock Down 0.9%

Shares of NASDAQ:KMTS opened at $27.74 on Friday. Kestra Medical Technologies, Ltd. has a 1-year low of $15.30 and a 1-year high of $30.00. The stock has a market cap of $1.63 billion, a P/E ratio of -11.46 and a beta of 0.58. The firm has a fifty day moving average price of $23.64 and a 200 day moving average price of $22.68. The company has a debt-to-equity ratio of 0.16, a current ratio of 4.41 and a quick ratio of 4.41.

Kestra Medical Technologies (NASDAQ:KMTS) last issued its quarterly earnings results on Tuesday, July 14th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.59) by ($0.08). The company had revenue of $28.64 million during the quarter. Kestra Medical Technologies had a negative net margin of 138.35% and a negative return on equity of 57.38%. Sell-side analysts predict that Kestra Medical Technologies, Ltd. will post -2.29 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on KMTS shares. BTIG Research increased their price objective on Kestra Medical Technologies from $30.00 to $32.00 and gave the stock a “buy” rating in a research report on Wednesday, July 15th. Weiss Ratings upgraded shares of Kestra Medical Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday. Wolfe Research set a $30.00 price target on shares of Kestra Medical Technologies in a research note on Wednesday, July 15th. Oppenheimer assumed coverage on shares of Kestra Medical Technologies in a report on Tuesday, July 21st. They issued a “market perform” rating for the company. Finally, Wall Street Zen raised shares of Kestra Medical Technologies from a “sell” rating to a “hold” rating in a report on Saturday, August 8th. Four equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $28.14.

Hedge Funds Weigh In On Kestra Medical Technologies

Several hedge funds and other institutional investors have recently bought and sold shares of KMTS. California State Teachers Retirement System grew its holdings in Kestra Medical Technologies by 39.2% in the first quarter. California State Teachers Retirement System now owns 27,835 shares of the company’s stock valued at $555,000 after purchasing an additional 7,844 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of Kestra Medical Technologies by 6.6% in the 1st quarter. The Manufacturers Life Insurance Company now owns 92,515 shares of the company’s stock worth $1,844,000 after buying an additional 5,731 shares in the last quarter. Quantinno Capital Management LP purchased a new stake in shares of Kestra Medical Technologies in the 1st quarter worth about $431,000. Sei Investments Co. grew its stake in Kestra Medical Technologies by 22.6% in the 1st quarter. Sei Investments Co. now owns 237,116 shares of the company’s stock valued at $4,726,000 after acquiring an additional 43,753 shares during the last quarter. Finally, Spartan Wealth Advisory Services LLC purchased a new position in Kestra Medical Technologies during the 1st quarter valued at about $603,000.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of our Cardiac Recovery System platform is the ASSURE WCD, a next generation wearable cardioverter defibrillator (“WCD”) used to protect patients at an elevated risk of sudden cardiac arrest (“SCA”), a major public health problem that accounts for approximately 50% of all cardiovascular deaths in the U.S.